Author: Neel Achary

Over 2.28 lakh modaks ordered on Swiggy this Ganesh Utsav, with Mumbai and Pune leading the celebrations

Mumbai, September 06, 2025: Swiggy (Swiggy Ltd, NSE: SWIGGY / BSE: 544285), India’s leading convenience platform, today shared that Ganesh Utsav was celebrated with full fervor across the country with the favorite festive delicacy- the modak. During Ganesh Utsav (between August 26 and September 3, 2025), customers across India ordered a staggering 2,28,102 modaks on the Swiggy platform.

A week of celebrations

The appetite for modaks remained strong throughout the festive week. Orders on Swiggy platform tripled in just a day, increasing from 29,674 orders on August 26 to peaking at 1,02,045 orders on Ganesh Chaturthi, August 27. The platform witnessed over 35% increase in orders compared to last year’s Ganesh Chaturthi.

Maharashtra Tops the Modak Charts as India celebrates

Maharashtra led the Ganesh Utsav celebrations, with Mumbai accounting for 69,240 modak orders and Pune for 30,433. They were followed by Nagpur, Nashik, and Amravati in Maharashtra.

With the festive cheer spreading across the country, while Mumbai and Pune topped the charts through the Ganesh Utsav week nationally, Bengaluru took third place, followed by Delhi and Kolkata. Emerging cities joined in the festivities as well, with Nashik, Vadodara, Surat, Dehradun, and Patna being the top 5.

The evolving Modaks

From classic Ukadiche Modaks in Maharashtra to Kesar and Mawa favorites across India, Swiggy’s data reflects how tradition and convenience played a central role in Ganesh Utsav 2025.

Nationally, Mawa Modak (8742 orders) emerged as the top choice, followed by Kesar Modak , Coconut Modak, Ukadiche Modak, and Kaju Modak.

In Maharashtra, tradition ruled—Ukadiche Modak led with 4,460 orders, followed by Mawa and Malai. Smaller pack sizes were popular too, with Mawa Modak (2 pcs) recording 2,983 orders.

GST Cut on Life-Saving Drugs Boosts Affordability, Access, and Innovation

Dr. Shravan Subramanyam, MD of BPL Medical Technologies

The reduction of GST on life-saving drugs, diagnostic kits, and medical equipment from 12% to 5% is a landmark reform. For patients, this translates into lower treatment costs and better access to advanced medical care. For us, it allows greater price competitiveness, helping us pass on the benefit to customers while strengthening our reach across hospitals, clinics, and homecare segments. We see this as a big enabler for growth, as it supports our mission of delivering affordable, world-class, ‘Made in India’ medical solutions while empowering us to scale up innovation and expand into newer markets.

BIX 2025 Set to Ignite Global Biopharma Innovation

SEOUL, South Korea|September 06, 2025 – With a bold focus on transformative technologies like AI-powered drug discovery, personalized medicine breakthroughs, and sustainable manufacturing practices, BIOPLUS-INTERPHEX KOREA (BIX) 2025 is poised to be the ultimate destination for biopharma leaders and innovators. Scheduled for October 15-17, 2025, at COEX Seoul, this year’s edition aims to serve as a catalyst for real-world progress across the global biopharma value chain.

Innovation Blooms at BIX 2025

Under the theme “Innovation Blooms No Matter What,” the BIX 2025 conference is designed as a springboard for addressing the industry’s most pressing challenges and opportunities. This year’s program features an impressive 36 sessions, including high-level keynotes,
16 Insight Sessions led by global pioneers, and 20 Technical Sessions offering field-specific expertise in R&D, regulatory strategies, and market commercialization. Ahead of the full program announcement, here’s a preview of two standout keynote sessions
and eight pivotal sessions that are set to shape the future of the biopharma industry:

Keynote Speakers and Breakthrough Sessions at BIX 2025

BIX 2025 is proud to present an exclusive preview of two remarkable keynote sessions and eight pivotal discussions that promise to shape the biopharmaceutical landscape. These sessions feature industry-leading experts and focus on new innovations and strategies
driving the future of biopharma.

Dr. Robert J. Hariri, Chairman & CEO, Celularity, Inc.

A trailblazer in biomedical science and cell-based therapeutics, Dr. Hariri brings decades of expertise to the stage. Renowned for being the first to isolate pluripotent stem cells from the human placenta, his groundbreaking advancements in immuno-oncology,
regenerative medicine, and cell therapy continue to redefine the field.

Keynote Address:  October 15 (Day 1), 10:15–10:45 AM, Room 401

Dr. David Berry, General Partner, Flagship Pioneering

A visionary biotech entrepreneur and thought leader, Dr. Berry has founded several game-changing startups, including Seres Therapeutics and Valo Health. His pioneering work in AI, the microbiome, and synthetic biology is transforming the way medicines and biotechnologies
are conceptualized and delivered.

Keynote Address:  October 16 (Day 2), 9:00–10:00 AM, Studio 159

Eight Breakthrough Sessions to Watch

AI in Drug Development: Real-World Applications and Limitations

Examine real-world applications of artificial intelligence in identifying drug targets, optimizing molecular design, and advancing clinical decision-making. This session, featuring case studies from global pharmaceutical leaders, showcases AI’s game-changing
potential while addressing its current limitations.

Anti-Aging as the Next Biotech Frontier

Delve into the revolutionary advancements driving the anti-aging sector, including scientific breakthroughs, regulatory challenges, and commercial opportunities. This session outlines pathways to leverage this booming market.

Scaling Digital Health Globally

Learn from Korean innovators on the forefront of digital health. From securing FDA approvals to forging global healthcare collaborations, this session highlights technologies that are reshaping patient care on an international scale.

New-Co Models: Risk Diversification or Scalable Innovation?

Industry leaders debate the strategic value of New-Co structures. Are these spin-offs the next leap in scalable innovation or merely tools for managing risk? Gain insights into what makes or breaks success in this evolving business approach.

Must Know About Navigating New Changes at US FDA: FDA’s Enhanced Foreign Inspections, Domestic Manufacturing Incentives, Artificial Intelligence Integration and More

With evolving FDA regulations, this session offers crucial guidance for Korean life sciences firms. Explore policy shifts around foreign manufacturing inspections, U.S.-based production incentives, and AI integration in regulatory processes, all explained by
top-notch FDA experts.

RLT (RadioLigand Therapy) Radiopharma Revolution: Unmet Needs, Innovation, and Global Access

Explore how radioligand therapy is revolutionizing cancer treatment. This world-class session covers innovation, global access, and unmet needs in precision medicine.

China Biotech’s ‘Deepseek’ Moment Is Coming. Are You Ready?

Analyze China’s meteoric rise in biotechnology, fueled by government initiatives and bold strategies for global expansion. Gain practical strategies for capitalizing on collaboration opportunities with this major market player.

Licensing-Out Strategies for K-Bio

Designed for Korean biopharma companies aiming to succeed globally, this session explores preclinical strategies, critical data requirements, and effective collaboration models, offering clear and actionable steps for global technology transfer.

More Than Ideas, It’s Where Connections Happen

At BIX 2025, innovation meets action. Beyond the sessions, the exhibition will showcase 550 booths from over 300 companies, featuring top-notch technologies and products already in use across the industry. With a focus on actionable insights and interactive
opportunities, attendees can connect with global thought leaders, policymakers, and market drivers, while exploring real-world solutions and engaging directly with the innovators shaping the future of the biopharma sector.

Secure Your Spot at BIX 2025

This year, BIX offers a range of passes designed to meet the unique needs of biotech professionals at every level:

All-Inclusive Pass: Full access to all conference sessions, exhibitions, and VIP networking programs. Exhibition Executive Pass: Curated for senior leaders focused on business development and licensing.

EE (Exhibition Executive) Pass: Focused on business matchmaking and high-level networking with exhibitors. Ideal for: Senior managers in business development, licensing, and distribution.

Standard Pass: Ideal for specialists in R&D, regulatory affairs, and global marketing.

Entry Pass: Perfect for attendees from academia, research institutions, and public-sector organizations.

Samsung Launches Galaxy Tab S11 Series with Redesigned S Pen and Enhanced Samsung DeX Experience

Bengaluru, India – September 6, 2025: Samsung, India’s largest consumer electronics brand, today announced the launch of the Galaxy Tab S11 Ultra and Galaxy Tab S11, delivering its most intelligent and advanced tablet experience yet. The Galaxy Tab S11 series is built for effortless productivity on the go, combining pro-grade hardware with experiences optimized for a large screen.

Galaxy Tab S11 Ultra is the thinnest Galaxy Tab to date. Without compromising performance, it goes beyond the slim form factor to show what a premium tablet can be. Galaxy Tab S11 Ultra is just 5.1 mm thick and weighs just 692 grams – versus its predecessor, which measured 5.5 mm and weighed 718 grams.

Powering Everyday Tasks with Advanced AI

With One UI 8, the Galaxy Tab S11 series brings multimodal AI to the forefront – understanding what users type, say and see, and responding in real time with helpful suggestions. These tools unlock a more fluid way to work, create and stay in flow across any task.

The Tab S11 series comes with Gemini Live that enables real-time screen sharing and visual input, so users can have a natural conversation with Gemini about what they’re looking at. Whether it’s on-screen content or an object that someone wants to show by pointing the camera at it – Gemini Live can handle contextual questions and requests by seeing what the user sees. For instance, users in a class can easily screen share their notes, then ask Gemini to interpret a chart or explain the study material and summarize its insights.

By pressing and holding the side button, users can activate Gemini and carry out commands across apps with a single command. For instance, when there’s no time to read a lengthy article, users can share the link with Gemini and say, “Summarize this article and save it to Samsung Notes,” making it easier to catch up later. It simplifies complex actions so users can stay in their flow.

Users can turn rough sketches into clean visuals with Drawing Assist, then drag and drop images they’ve created into Samsung Notes as a starting point for further ideation – perfect for brainstorming, visual planning or creative exploration. Writing Assist helps rework tone and style, so users can easily refine a piece of writing to ensure it matches their intended meaning before dropping it into an email, document or other apps. Circle to Search with Google is now even more helpful for getting context and diving deeper into anything users see on their device’s screen.

Redesigned S Pen

The Galaxy Tab S11 series comes with the newly redesigned S Pen that’s built for both focused work and creative expression. Its new cone-shaped pen tip supports increased tilt angles for better control, while a hexagonal design provides a more natural, ergonomic feel that’s comfortable and stable in the hand. Quick Tools make it easy to adjust on the fly while drawing or editing with floating access, while Sticky Note lets users capture sudden thoughts or to-dos directly over Samsung Notes – no more app switching required during document review.

Enhanced Samsung DeX

In addition to Galaxy AI, the enhanced Samsung DeX on the Galaxy Tab S11 series empowers users to maximize their productivity when multitasking across apps, taking notes during meetings or simply mapping out ideas. Whether you’re a designer building out visual concepts or a frequent traveler planning a trip across apps and displays, the Galaxy Tab S11 series features support every step, from researching and sketching to sharing polished results.

The latest Samsung DeX upgrades unlock next-level productivity, starting with Extended Mode, which transforms Galaxy Tab S11 and an external monitor into a seamless dual-screen setup. It runs Samsung DeX across both screens simultaneously for more intuitive multitasking and greater flexibility – now users can drag and drop apps between displays or reference a document on one screen while presenting on the other. Also new to Samsung DeX, users can now create up to four separate, customized workspaces for different needs. For example, one workspace can be dedicated for work, another to creative projects and a third to planning a trip.

With the upgraded Samsung DeX, users can set up a full working environment from virtually anywhere – whether it’s connecting to a meeting room TV for a presentation or adding final touches to a work document at the airport lounge just before starting a vacation.

Combined with Book Cover Keyboard Slim, the Galaxy Tab S11 series easily transforms into a personalized, mobile workstation with instant access to AI assistants through the dedicated Galaxy AI Key. 

Made To Perform, Built To Move

The Galaxy Tab S11 series delivers its most advanced performance yet, equipped with cutting-edge hardware and immersive visuals in a slim, highly portable design. Samsung brings its enhanced 3nm processor to Galaxy Tab for the first time in the S11 series, offering faster processing, smoother multitasking and more responsive AI features. Galaxy Tab S11 Ultra boasts performance improvements of 33% in NPU, 24% in CPU and 27% in GPU.

Performance matched by purposeful design reflects Samsung’s hardware innovation – delivering ultra-thin and light, yet powerful devices ready for everyday versatility. Galaxy Tab S11 Ultra features a remarkably slim build at just 5.1 mm, with narrow 5.2 mm bezels that expand screen space without compromising portability. Across both models, Dynamic AMOLED 2X displays deliver up to 1600 nits of peak brightness, ensuring clear, vivid visuals indoors or out, so users can stay focused wherever they work.

Availability, Pre Book Offers & Pricing

The Galaxy Tab S11 series will be available for pre-orders starting today. Customers who pre-order the new Tab S11 series will get 45W travel adapter free of charge. The Galaxy Tab S11 series is priced starting

INR 74999 and is offered in two colours: Gray and Silver. Consumers can purchase the new Galaxy Tab S11 series on Samsung.com, Samsung Exclusive Stores, select Samsung authorized retail stores, and other online portals. The Galaxy Tab S11 series is available with 9-month no-cost bank EMI and also comes with 24-month EMIs in case the devices are financed from NBFCs.